These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 21513124

  • 1. [Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease].
    Strippoli S, Stucci S, Dammacco F, Silvestris F.
    Recenti Prog Med; 2011 Feb; 102(2):88-95. PubMed ID: 21513124
    [Abstract] [Full Text] [Related]

  • 2. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 3. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
    Yao NS, Wu YY, Janckila AJ, Ku CH, Hsieh AT, Ho CL, Lee SH, Chao TY.
    Clin Chim Acta; 2011 Jan 14; 412(1-2):181-5. PubMed ID: 20932965
    [Abstract] [Full Text] [Related]

  • 4. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
    Mose S, Menzel C, Kurth AA, Obert K, Breidert I, Borowsky K, Böttcher HD.
    Anticancer Res; 2003 Jan 14; 23(3C):2783-8. PubMed ID: 12926113
    [Abstract] [Full Text] [Related]

  • 5. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY, Wu YY, Janckila AJ.
    Clin Chim Acta; 2010 Nov 11; 411(21-22):1553-64. PubMed ID: 20599857
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
    Mose S, Menzel C, Kurth AA, Obert K, Ramm U, Eberlein K, Boettcher HD, Pichlmeier U.
    Anticancer Res; 2005 Nov 11; 25(6C):4639-45. PubMed ID: 16334155
    [Abstract] [Full Text] [Related]

  • 7. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
    Salminen E, Ala-Houhala M, Korpela J, Varpula M, Tiitinen SL, Halleen JM, Väänänen HK.
    Acta Oncol; 2005 Nov 11; 44(7):742-7. PubMed ID: 16227166
    [Abstract] [Full Text] [Related]

  • 8. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
    Korpela J, Tiitinen SL, Hiekkanen H, Halleen JM, Selander KS, Väänänen HK, Suominen P, Helenius H, Salminen E.
    Anticancer Res; 2006 Nov 11; 26(4B):3127-32. PubMed ID: 16886645
    [Abstract] [Full Text] [Related]

  • 9. Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
    Wada N, Ishii S, Ikeda T, Enomoto K, Kitajima M.
    Anticancer Res; 1999 Nov 11; 19(5C):4515-21. PubMed ID: 10650803
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X.
    Clin Chim Acta; 2013 Nov 15; 426():102-7. PubMed ID: 24055775
    [Abstract] [Full Text] [Related]

  • 11. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK.
    Clin Lab; 2006 Nov 15; 52(9-10):499-509. PubMed ID: 17078477
    [Abstract] [Full Text] [Related]

  • 12. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Ozu C, Nakashima J, Horiguchi Y, Oya M, Ohigashi T, Murai M.
    Int J Urol; 2008 May 15; 15(5):419-22. PubMed ID: 18452459
    [Abstract] [Full Text] [Related]

  • 13. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM.
    Anticancer Res; 2003 May 15; 23(2A):1027-9. PubMed ID: 12820342
    [Abstract] [Full Text] [Related]

  • 14. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC, Ku CH, Chao TY, Yu JC, Chen MM, Lee SH.
    Cancer Epidemiol Biomarkers Prev; 2006 Mar 15; 15(3):424-8. PubMed ID: 16537696
    [Abstract] [Full Text] [Related]

  • 15. Survival markers related to bone metastases in prostate cancer.
    Salminen EK, Kallioinen MJ, Ala-Houhala MA, Vihinen PP, Tiitinen SL, Varpula M, Vahlberg TJ.
    Anticancer Res; 2006 Mar 15; 26(6C):4879-84. PubMed ID: 17214355
    [Abstract] [Full Text] [Related]

  • 16. Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
    Windrichova J, Fuchsova R, Kucera R, Topolcan O, Fiala O, Finek J, Slipkova D, Karlikova M, Svobodova J.
    Anticancer Res; 2016 Apr 15; 36(4):1973-8. PubMed ID: 27069189
    [Abstract] [Full Text] [Related]

  • 17. Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
    Wu YY, Janckila AJ, Ku CH, Yu CP, Yu JC, Lee SH, Liu HY, Yam LT, Chao TY.
    BMC Cancer; 2010 Apr 23; 10():158. PubMed ID: 20416078
    [Abstract] [Full Text] [Related]

  • 18. [TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
    Dedkov AG, Boychuk SI, Stakhovsky EA, Kukushkina MN, Kovalchuk PA.
    Lik Sprava; 2015 Apr 23; (5-6):104-9. PubMed ID: 27089726
    [Abstract] [Full Text] [Related]

  • 19. Biochemical markers of bone metabolism in breast cancer.
    Lyubimova NV, Kozharskaya GV, Portnoi SM, Kushlinskii NE.
    Bull Exp Biol Med; 2014 Oct 23; 157(6):769-72. PubMed ID: 25342482
    [Abstract] [Full Text] [Related]

  • 20. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z, Konieczna M, Saracyn M, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr 23; 24(142):351-4. PubMed ID: 18634372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.